期刊文献+

二乙酰己二胺诱导骨髓增生异常综合征MUTZ-1细胞凋亡及其机制研究 被引量:1

Effect of CAHB on apoptosis of MUTZ-1 cells and its mechanism
下载PDF
导出
摘要 目的体外研究二乙酰己二胺(CAHB)对人骨髓增生异常综合征(MDS)细胞株MUTZ-1细胞的作用以及可能的作用机制。方法用CAHB处理MUTZ-1细胞,光学显微镜下观察不同浓度的CAHB处理后MUTZ-1细胞形态的改变;利用四甲基偶氮唑盐比色法(MTT法)检测CAHB对MUTZ-1细胞的增殖抑制作用;采用流式细胞仪分析细胞DNA含量分布变化;利用RT-PCR技术检测凋亡相关基因Survivin、Bcl-2的表达变化。结果CAHB能抑制MUTZ-1细胞的生长,具有浓度和时间依赖性;随着CAHB药物浓度的增加MUTZ-1细胞出现凋亡细胞的典型形态学特征改变;CAHB作用后,MUTZ-1细胞的DNA含量在细胞周期的分布有明显变化,G0/G1期细胞比例无明显变化,S期细胞减少,而G2/M期细胞增多,细胞被阻滞在G2期,呈浓度依赖;在细胞凋亡过程中抗凋亡基因Bcl-2、Survivin基因下调。结论CAHB不但能抑制MUTZ-1细胞生长而且能诱导细胞凋亡,诱导细胞凋亡是其主要细胞毒作用之一。抗凋亡基因Bcl-2、Survivin基因下调可能是其诱导细胞凋亡的机制之一。 Objective To investigate the effect of CAHB on the apoptosis of MUTZ-1 ceils in vitro and its mechanism. Methods The morphologic features of MUTZ-1 cells were observed using light microscopy, cell growth was measure by MTT assay, cell cycle was detected by flow cytometry and mRNA expression of survivin and Bcl-2 genes was detected by RT-PCR methods. Results MTT assay showed that treatment with CAHB remarkably inhibited the growth of MUTZ-1 cells in a dose-dependent and time-dependent manners. The typical apoptotic morphological features appeared in cells treated with CAHB. Flow cytometry showed that MUTZ-1 cells had a dose-dependent apoptosis after cultured with CAHB for 24 h. CAHB treatment decreased S phase ceils, increased G2/M phase ceils, but G0/G1 phase did not changed. RT-PCR showed that survivin and Bcl-2 inhibit MUTZ-1 cell growth and induce cell apoptosis survivin genes in MUTZ-1 cells. mRNA down-regulated in MUTZ-1 cells. Conclusion CAHB can which may be associated with down-regulation of Bcl-2 and survivin genes in MUTZ-1 cells.
出处 《浙江医学》 CAS 2008年第5期466-469,共4页 Zhejiang Medical Journal
关键词 骨髓增生异常综合征 细胞凋亡 二乙酰己二胺 MUTZ-1细胞 Myelodysplastic syndromes Apoptosis CAHB MUTZ-1 cell
  • 相关文献

参考文献5

二级参考文献12

  • 1Humphrey PA, Wong A J, Vogelstein B, et al. Amplification and expression of EGFR in Human glioma xenografts[J]. Cancer Res, 1998, 48:2 231-2 238.
  • 2Verhagen AM, Ekort PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins[J]. Cell, 2000,102 (1):43-53.
  • 3Sasaki T, Lopes MB, Hankins GR, et al. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system [J]. Acta Neuropathol, 2002,104 (1) : 105 - 109.
  • 4Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/pl6INK4a and Cdk2/CyclinE complex activation[J]. Oncogene, 2000,19 (29): 3 225-3 228.
  • 5Chakravati A, Komaga T, Firoozbakht F, et al. Placental growth factor is a survival factor for tumor endothelial cells and macrophages[J]. Cancer Res, 2002,62(10):2 749-2 752.
  • 6Serrano M, Hannon GY, Beach DA. A new regulatory motifin cell cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366 (16):704-708.
  • 7Marx J. New tumor suppressor may rival p53[J]. Science ,1994,264: 344-347.
  • 8Lukas J, Aagaard L, Strauss M, et al. Oncogen icaberrations of p16ink4/CDKN2 and cyclinD1 cooperate to deregulate G1 control[J]. Cancer Res,1996,55:1 355-1 357.
  • 9彭黎明 王曾礼.细胞凋亡的基础和临床[M].北京:人民卫生出版社,2000.40-45.
  • 10Barbara A. Conley,Merrill J. Egorin,Victoria Sinibaldi,Gerald Sewack,Curtis Kloc,Lynelle Roberts,Eleanor G. Zuhowski,Alan Forrest,David A. Echo. Approaches to optimal dosing of hexamethylene bisacetamide[J] 1992,Cancer Chemotherapy and Pharmacology(1):37~45

共引文献7

同被引文献12

  • 1陈勤奋,李佩,范学良,张少峰,李中东,梁晓华,陈彤,谢彦晖,谢毅.二乙酰己二胺治疗骨髓增生异常综合征患者的Ⅰ期临床研究[J].中华内科杂志,2004,43(7):534-535. 被引量:5
  • 2Gutierrez A, Sanda T, Grebliunaite R, et al. High frequency of PTEN, PI3 K, and AKT abnormalities in T - cell acute lymphoblastic leukemia [ J ]. Blood,2009,114 ( 3 ) :647 - 650.
  • 3Vitale A, Guarini A, Ariola C, et al. Adult T - cell acute lympho- blastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol [ J ]. Blood,2006,107 (2) :473 - 479.
  • 4Ruefli A A, Smyth M J, Johnstone R W. HMBA induces activation of a caspase - independent cell death pathway to overcome P - glycopro- rein - mediated muhidrug resistance [ J ]. Blood, 2000,95 ( 7 ) : 2378 -2385.
  • 5Evangelisti C, Evangelisti C, Chiarini F, et al. Therapeutic potential of targeting mTOR in T - cell acute lymphoblastic leukemia (review) [J]. Int JOncol,2014,45(3):909-918.
  • 6Thorpe LM, Yuzugullu H, Zhao JJ. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting [ J ]. Nat Rev Cancer,2015,15 ( 1 ) :7 - 24.
  • 7Iturri P, Joseph V, Rodrigo G, et al. Inhibition of protein kinases AKT and ERK1/2 reduce the carotid body chemoreceptor response to hypoxia in adult rats[J]. Adv Exp Med Biol,2015,860:269 -277.
  • 8Sunayama J, Sato A, Matsuda K, et al. Dual blocking of mTor and PI3 K elicits a prodifferentiation effect on glioblastoma stem - like cells [J]. NeuroOncol,2010,12(12):1205-1219.
  • 9陈勤奋,范维琥,李佩,山缨,林茂芳,蔡真,邹善华,何静松,丁天凌,袁燕,程志祥,谢毅.二乙酰己二胺(CAHB)治疗骨髓增生异常综合征(MDS)的心脏安全性临床评价[J].中国新药杂志,2008,17(6):512-515. 被引量:2
  • 10李洋,杨东波,张俊和,陈灵朝,蒋传路.LY294002通过抑制胶质瘤的PI3K/Akt通路增强三氧化二砷毒性作用[J].哈尔滨医科大学学报,2014,48(1):13-17. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部